Johnson & Johnson’s TB drug SIRTURO receives full approval from FDA and EC
In a significant development for the treatment of drug-resistant tuberculosis (TB), Johnson & Johnson has announced that SIRTURO (bedaquiline) has received full approval from the ... Read More
Understanding and Combating Tuberculosis: A Comprehensive Guide
Tuberculosis (TB) remains one of the most persistent and deadly infectious diseases globally. Caused by various strains of the Mycobacterium tuberculosis bacteria, TB primarily targets ... Read More